Vaccine Associated Feline Sarcoma Task
Force Update – January 9, 2002
The Vaccine-Associated Feline
Sarcoma Task Force (VAFSTF) met in March 2001 at the American Veterinary Medical
Association (AVMA) headquarters to award grants to research proposals scored by
independent reviewers. This year is
marked by continuing financial support for studies investigating the
epidemiology, etiology, and treatment of these rare but aggressive tumors. In addition to the publication of Guidelines:
Diagnosis and Management of Suspected Sarcomas
and Report: Vaccine-Associated
Feline Sarcomas, the findings of several task force-funded projects
have been published in peer-reviewed veterinary journals.
As
of December 2001, various veterinary organizations, individuals, and vaccine
manufacturers have contributed over $788,000 toward task force research
projects. The task force wishes to
thank the following for their generous contributions:
|
Organizations: |
2001 Donation |
Total 1997-2001 |
|
American
Animal Hospital Association Foundation |
|
$ 100,000 |
|
American
Association of Feline Practitioners |
$ 10,000 |
$ 55,000 |
|
American
Veterinary Medical Association |
|
$ 50,000 |
|
Cornell
Feline Health Center |
$ 10,000 |
$ 40,000 |
|
Veterinary
Cancer Society |
|
$ 15,000 |
|
Ohio
Animal Health Foundation |
|
$ 5,000 |
|
Individuals: |
100 |
$
978 |
|
|
$ 20,100 |
$
265,978 |
|
Manufacturers: |
2001 Donation |
Total 1997-2001 |
|
|
Pfizer Animal Health |
25,000 |
250,000 |
|
|
Fort Dodge Animal Health |
25,000 |
100,000 |
|
|
Novartis Animal Health |
|
45,000 |
|
|
Intervet Inc. |
10,000 |
40,000 |
|
|
Merial |
|
30,000 |
|
|
Schering-Plough Animal Health |
|
30,000 |
|
|
Biocor Animal Health |
15,000 |
15,000 |
|
|
Bayer Animal Health |
|
10,000 |
|
|
Synbiotics |
|
2,500 |
|
|
|
$75,000 |
$
522,500 |
|
|
|
Grand Total 1997-2001 |
$
788,478 |
This
support has allowed funding of the following three 2000-2001 projects:
·
Molecular
Biomarkers of Vaccine-Associated Feline Sarcomas: Alterations in Gene
Expression during Tumor Development.
Principal
investigator - Sagarika Kanjilal, Ph.D.
·
Evaluation of
Mutagenicity of Feline Vaccines Using the AL Assay: Year 3.
Principal investigator
- Elizabeth A. McNiel, D.V.M., Ph.D.
·
Phase II Evaluation of Ifosfamide in Cats with
Spontaneously-Occurring Soft Tissue Sarcomas
Principal
investigator – Kenneth Rassnick, D.V.M.
The VAFSTF is an alliance of four national veterinary organizations along with representatives from academia, industry, and USDA-APHIS. For continued updating on the activities of the VAFSTF, visit the task force’s web site at http://www.avma.org/vafstf.
To return to Sylvia's Cyber Kitty Condo Just Scratch Her Banner Below...
